[SCHEDULE 13G/A] ELI LILLY & Co SEC Filing

Rhea-AI Filing Summary

Lilly Endowment, Inc. filed Amendment No. 43 to Schedule 13G reporting beneficial ownership of 95,492,993 shares of Eli Lilly (LLY) common stock, representing 10.1% of the class. The ownership is reported as of September 30, 2025, and the percentage is based on 946,456,759 shares outstanding as of August 4, 2025 per the issuer’s Form 10‑Q.

The Endowment has sole voting power and sole dispositive power over 95,492,993 shares, with no shared voting or dispositive power. The filer is an Indiana not‑for‑profit organization and private foundation.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 43)

ELI LILLY AND COMPANY

(Name of Issuer)

Common Stock, Without Par Value

(Title of Class of Securities)

532457108

(CUSIP Number)

09/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 532457108

1

Names of Reporting Persons

LILLY ENDOWMENT, INC.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

INDIANA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 95,492,993.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 95,492,993.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

95,492,993.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

10.1 %

12

Type of Reporting Person (See Instructions)

CO

Comment for Type of Reporting Person: The percentage of class represented is based on 946,456,759 shares of common stock outstanding as of August 4, 2025 (the most recent date for which such information is publicly available), as reported in the Issuer's Form 10-Q for the period ended June 30, 2025. This information is provided as of September 30, 2025.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: ELI LILLY AND COMPANY
(b)	Address of issuer's principal executive offices: LILLY CORPORATE CTR, DROP CODE 1094, INDIANAPOLIS, IN, 46285.
Item 2.
(a)	Name of person filing: This statement is filed by Lilly Endowment, Inc., a not for profit corporation organized under the laws of the State of Indiana. Lilly Endowment, Inc. is an organization described in Section 501(c)(3) of the Internal Revenue Code of 1986, as amended (the Code), and is a private foundation under Section 509(a) of the Code.
(b)	Address or principal business office or, if none, residence: The address of the principal business office of Lilly Endowment, Inc. is 2801 North Meridian Street, Indianapolis, IN 46208.
(c)	Citizenship: Indiana
(d)	Title of class of securities: Common Stock, Without Par Value
(e)	CUSIP No.: 532457108
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 95,492,993 shares as of September 30, 2025 - None of such shares are deemed to be beneficially owned by reason of the possession of Lilly Endowment, Inc. of a right to acquire such shares.
(b)	Percent of class: 10.1%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 95,492,993 shares
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 95,492,993 shares
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.	Certifications:
	Not Applicable

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

LILLY ENDOWMENT, INC.

Signature:	Diane M. Stenson
Name/Title:	Vice President and Treasurer
Date:	10/30/2025

FAQ

What stake in Eli Lilly (LLY) does Lilly Endowment report?

Lilly Endowment reports beneficial ownership of 95,492,993 shares, or 10.1% of Eli Lilly’s common stock.

As of what date are the ownership figures reported for LLY?

The ownership amounts are reported as of September 30, 2025.

What share count underlies the 10.1% figure for LLY?

The percentage is based on 946,456,759 shares outstanding as of August 4, 2025, per Eli Lilly’s Form 10‑Q.

Does Lilly Endowment have sole or shared voting power over LLY shares?

It has sole voting power over 95,492,993 shares and no shared voting power.

Does Lilly Endowment have dispositive power over its LLY shares?

It has sole dispositive power over 95,492,993 shares and no shared dispositive power.

What filing was made regarding LLY and by whom?

An Amendment No. 43 to Schedule 13G was filed by Lilly Endowment, Inc. regarding Eli Lilly common stock.